Archive

Population based estimates of comorbidities affecting risk for complications from COVID-19 in the US
Mary L. Adams, David L. Katz, Joseph Grandpre

medRxiv 2020.03.30.20043919; doi: https://doi.org/10.1101/2020.03.30.20043919
SPONTANEOUS ECHO CONTRAST IN MITRAL STENOSIS: WHY AND HOW?
Ziya Gokalp Bilgel, Ibrahim Hakan Gullu, Saif Hamad, Mutlu Kasar, Tansel Erol, Senol Demircan, Haldun MUderrisoglu

medRxiv 2020.03.31.20046318; doi: https://doi.org/10.1101/2020.03.31.20046318
Clinical features and outcomes of 2019 novel coronavirus-infected patients with high plasma BNP levels
Youbin Liu, Dehui Liu, Huafeng Song, Chunlin Chen, Mingfang Lv, Xing Pei, Zhongwei Hu, Zhihui Qin, Jinglong Li

medRxiv 2020.03.31.20047142; doi: https://doi.org/10.1101/2020.03.31.20047142
Flattening the curve is not enough, we need to squash it: An explainer using a simple model
ES McBryde, MT Meehan, JM Trauer

medRxiv 2020.03.30.20048009; doi: https://doi.org/10.1101/2020.03.30.20048009
Research on the Influence of Information Diffusion on the Transmission of the Novel Coronavirus (COVID-19)
Shanlang Lin, Chao Ma, Ruofei Lin, Junpei Huang, Ruohan Xu, Aini Yuan

medRxiv 2020.03.31.20048439; doi: https://doi.org/10.1101/2020.03.31.20048439
Harnessing the 100,000 Genomes Project whole genome sequencing data - an unbiased systematic tool to filter by biologically validated regions of functionality
Sihao Xiao, Zhentian Kai, David Brown, Genomics England Research Consortium, Claire L Shovlin

medRxiv 2020.03.30.20047209; doi: https://doi.org/10.1101/2020.03.30.20047209
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression
Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Alessandro Serretti, Cathryn M. Lewis

medRxiv 2020.03.31.20048538; doi: https://doi.org/10.1101/2020.03.31.20048538
Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center
Ting Xue, Qianwen Li, Qiongyao Zhang, Wei Lin, Junping Wen, Li Li, Gang Chen

medRxiv 2020.03.31.20048579; doi: https://doi.org/10.1101/2020.03.31.20048579
A Gaussian model for the time development of the Sars-Cov-2 corona pandemic disease. Predictions for Germany made on March 30, 2020
R. Schlickeiser, F. Schlickeiser

medRxiv 2020.03.31.20048942; doi: https://doi.org/10.1101/2020.03.31.20048942
Differences in power-law growth over time and indicators of COVID-19 pandemic progression worldwide
Jack Merrin

medRxiv 2020.03.31.20048827; doi: https://doi.org/10.1101/2020.03.31.20048827

Pages